Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions
Jie Du, … , S. Russ Price, William E. Mitch
Jie Du, … , S. Russ Price, William E. Mitch
Published January 1, 2004
Citation Information: J Clin Invest. 2004;113(1):115-123. https://doi.org/10.1172/JCI18330.
View: Text | PDF
Article

Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions

  • Text
  • PDF
Abstract

With trauma, sepsis, cancer, or uremia, animals or patients experience accelerated degradation of muscle protein in the ATP-ubiquitin-proteasome (Ub-P’some) system. The initial step in myofibrillar proteolysis is unknown because this proteolytic system does not break down actomyosin complexes or myofibrils, even though it degrades monomeric actin or myosin. Since cytokines or insulin resistance are common in catabolic states and will activate caspases, we examined whether caspase-3 would break down actomyosin. We found that recombinant caspase-3 cleaves actomyosin, producing a characteristic, approximately 14-kDa actin fragment and other proteins that are degraded by the Ub-P’some. In fact, limited actomyosin cleavage by caspase-3 yields a 125% increase in protein degradation by the Ub-P’some system. Serum deprivation of L6 muscle cells stimulates actin cleavage and proteolysis; insulin blocks these responses by a mechanism requiring PI3K. Cleaved actin fragments are present in muscles of rats with muscle atrophy from diabetes or chronic uremia. Accumulation of actin fragments and the rate of proteolysis in muscle stimulated by diabetes are suppressed by a caspase-3 inhibitor. Thus, in catabolic conditions, an initial step resulting in loss of muscle protein is activation of caspase-3, yielding proteins that are degraded by the Ub-P’some system. Therapeutic strategies could be designed to prevent these events.

Authors

Jie Du, Xiaonan Wang, Christiane Miereles, James L. Bailey, Richard Debigare, Bin Zheng, S. Russ Price, William E. Mitch

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Actin fragment degradation requires ATP, proteasome activity, and caspas...
Actin fragment degradation requires ATP, proteasome activity, and caspase-3. (a) L6 cells were incubated with staurosporine to activate caspase-3 as in Figure 2. Cell lysates were incubated on ice or at 37°C for 3 hours as indicated. We then tested for production of the 14-kDa actin fragment. When we added 2 mM ATP, the accumulation of the fragment was largely eliminated, and this outcome was blocked by adding MG132 (10 μM). (b) Lysates from control or staurosporine-treated cells were incubated for 3 hours at 37°C with Ac-DEVD-CHO (DEVD) (5 μM), and Western blot analysis revealed that caspase-3 was responsible for the appearance of the 14-kDa actin fragment.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts